Search - tctmd.com

Displaying 61 - 80 of 6833

Sort: Relevancy | Date

Presentation THT 2026

Percutaneous Pericardiotomy as a Treatment for HFpEF (Heart Failure Solutions)

Presenter: Barry Borlaug

March 03, 2026

Presentation THT 2026

Psoas Muscle Recovery After LVAD Implantation is Associated with Decreased Risk of Heart Failure Readmission in Cardiogenic Shock Patients

Presenter: Robert Anthony Adamian

March 03, 2026

Presentation THT 2026

LVEF and Functional Improvement Observed in a Post-Market Registry of Barostim Baroreflex Activation Therapy

Presenter: Dmitry Yaranov

March 03, 2026

Presentation THT 2026

Real-World Outcomes of Barostim Baroreflex Activation Therapy in Heart Failure: Analysis of a Large Multi-Institutional Database.

Presenter: Arvind Bhimaraj

March 03, 2026

News Daily News

AHA Forecast: CV Risk Factors in Women, Girls Headed in Wrong Direction

L.A. McKeown

March 03, 2026

Presentation THT 2026

Impact of Pharmacist Virtual Consultation on GDMT Optimization in Hospitalized Patients

Presenter: Brad Williams

March 03, 2026

Presentation THT 2026

Ultrasound Pulmonary Artery Denervation as a Treatment for Heart Failure (Gradient Medical)

Presenter: Alex Rothman

March 03, 2026

Presentation THT 2026

Supervised Learning vs. Foundation Models: A Comparative Appraisal of PanEcho and EchoPrime for Heart Failure Phenotyping

Presenter: Ahmad Nusairat

March 03, 2026

Presentation THT 2026

Radiofrequency Pulmonary Artery Denervation for Heart Failure (Pulnovo)

Presenter: Giora Weisz

March 03, 2026

Presentation THT 2026

Real-World Comparison of Finerenone and Steroidal Mineralocorticoid Receptor Antagonists in Patients With Heart Failure With Reduced Ejection Fraction

Presenter: Thitiphan Srikulmontri

March 03, 2026

Presentation THT 2026

An Emerging Problem: TR in Advanced Heart Failure (LVAD, OHT) Patients

Presenter: Michael I. Brener

March 03, 2026

Presentation THT 2026

Early Interventions in Heart Failure Medications, Changes in Pulmonary Artery Pressure and Risk of Outcomes in Chronic Heart Failure Patients

Presenter: Sandip K. Zalawadiya

March 03, 2026

Presentation THT 2026

Renal Denervation Beyond HTN: Implications and the Intersection Between Heart Failure and Fatty Liver

Presenter: David E. Kandzari

March 03, 2026

Presentation THT Abstracts 2026

Use of a Novel Pulmonary Artery Pressure Metric to Identify Risk in Ambulatory Heart Failure Patients.

Presenter: Sirish Vullaganti

March 03, 2026

Presentation THT Abstracts 2026

Real-World Adherence to CardioMEMS Transmissions and Associations with Clinical Outcomes

Presenter: Sirish Vullaganti

March 03, 2026

Presentation THT Abstracts 2026

High Risk PCI with Hemodynamic Optimization Peri-revascularization (HiHO)

Presenter: Jared Romeo

March 03, 2026

Presentation THT Abstracts 2026

The Impact of Aortic Stenosis on the Obesity Paradox in Acute Decompensated Heart Failure

Presenter: Bryce Allen

March 03, 2026

Presentation THT Abstracts 2026

Impact of Pulmonary Hypertension Subtypes on Clinical Outcomes and Resource Utilization in Heart Failure

Presenter: Bryce Allen

March 03, 2026

Presentation THT Abstracts 2026

Tailoring MCS in Cardiogenic Shock

Presenter: Brett Cohen

March 03, 2026

Presentation THT Abstracts 2026

Potassium Levels and In-Hospital Mortality in Acute Heart Failure

Presenter: Aarjuv Majmundar

March 03, 2026

Advertisement

Percutaneous Pericardiotomy as a Treatment for HFpEF (Heart Failure Solutions)

Psoas Muscle Recovery After LVAD Implantation is Associated with Decreased Risk of Heart Failure Readmission in Cardiogenic Shock Patients

LVEF and Functional Improvement Observed in a Post-Market Registry of Barostim Baroreflex Activation Therapy

Real-World Outcomes of Barostim Baroreflex Activation Therapy in Heart Failure: Analysis of a Large Multi-Institutional Database.

AHA Forecast: CV Risk Factors in Women, Girls Headed in Wrong Direction

Impact of Pharmacist Virtual Consultation on GDMT Optimization in Hospitalized Patients

Ultrasound Pulmonary Artery Denervation as a Treatment for Heart Failure (Gradient Medical)

Supervised Learning vs. Foundation Models: A Comparative Appraisal of PanEcho and EchoPrime for Heart Failure Phenotyping

Radiofrequency Pulmonary Artery Denervation for Heart Failure (Pulnovo)

Real-World Comparison of Finerenone and Steroidal Mineralocorticoid Receptor Antagonists in Patients With Heart Failure With Reduced Ejection Fraction

An Emerging Problem: TR in Advanced Heart Failure (LVAD, OHT) Patients

Early Interventions in Heart Failure Medications, Changes in Pulmonary Artery Pressure and Risk of Outcomes in Chronic Heart Failure Patients

Renal Denervation Beyond HTN: Implications and the Intersection Between Heart Failure and Fatty Liver

Use of a Novel Pulmonary Artery Pressure Metric to Identify Risk in Ambulatory Heart Failure Patients.

Real-World Adherence to CardioMEMS Transmissions and Associations with Clinical Outcomes

High Risk PCI with Hemodynamic Optimization Peri-revascularization (HiHO)

The Impact of Aortic Stenosis on the Obesity Paradox in Acute Decompensated Heart Failure

Impact of Pulmonary Hypertension Subtypes on Clinical Outcomes and Resource Utilization in Heart Failure

Tailoring MCS in Cardiogenic Shock

Potassium Levels and In-Hospital Mortality in Acute Heart Failure

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content